Clinical Trials Logo

X-Linked Agammaglobulinemia clinical trials

View clinical trials related to X-Linked Agammaglobulinemia.

Filter by:
  • Recruiting  
  • Page 1

NCT ID: NCT05321407 Recruiting - Clinical trials for Common Variable Immunodeficiency

COVID-19 Vaccine Responses in PIDD Subjects

Start date: September 24, 2021
Phase:
Study type: Observational

The goal of our study is to assess the cellular immune responses of participants with antibody deficiency disease before and after immunization with SARS-CoV-2 mRNA vaccines.

NCT ID: NCT01821781 Recruiting - Clinical trials for Chronic Granulomatous Disease

Immune Disorder HSCT Protocol

Start date: March 2013
Phase: Phase 2
Study type: Interventional

This study hypothesizes that a reduced intensity immunosuppressive preparative regimen will establish engraftment of donor hematopoietic cells with acceptable early and delayed toxicity in patients with immune function disorders. A regimen that maximizes host immune suppression is expected to reduce graft rejection and optimize donor cell engraftment.